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Evolutionary de novo design is the design of new active
compounds from scratch, using evolutionary principles.
It involves an iterative cycle of structure generation, eva-
luation, and selection of candidate structures. Selected
candidates serve as input for the next generation. By
repeatedly selecting only the best structures as basis for
structure generation, the process evolves toward better
(not necessarily best) solutions. Here, we applied an evo-
lutionary algorithm (the Molecule Commander) for the
design of selective adenosine receptor ligands. Generated
compounds were all rule-of-5 compliant and had a polar
surface areas between 0 and 140 Å
2, favorable for intest-
inal absorption. In addition, toxic compounds were fil-
tered out using a categorical SVM model for prediction
of mutagenicity trained on Ames-test mutagenicity data
(5-fold ROC score: 0.8948). Four pharmacophores were
designed, one for each human adenosine receptor
subtype. The hA1 receptor pharmacophore served as
objective for the evolution, while the three other phar-
macophores served as negative objective in order to
obtain selectivity. In order to measure similarity with
known adenosine receptor ligands, ring systems and
scaffolds in the generated compounds were compared
with those extracted from adenosine ligands in the
StARLITe database. With each new generation, the
structures displayed an increasing number of ring sys-
tems also found in adenosine receptor ligands while the
number of unique core structures (scaffolds) increased
as well. Eventually, the best (ADMET and pharmaco-
phore score) candidate structures will be proposed for
synthesis and tested for activity.
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